ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

NXGL NexGel Inc

2.21
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
NexGel Inc NXGL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 2.21 17:00:00
개장가 저가 고가 종가 전일 종가
2.21
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
18/04/202421:00GLOBENEXGEL to Present at the Planet MicroCap Showcase: VEGAS..
01/04/202420:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
27/03/202422:00GLOBENEXGEL Reschedules Fourth Quarter and Full Year 2023..
21/03/202422:00GLOBENEXGEL to Report Fourth Quarter and Full Year 2023 Financial..
05/03/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/03/202422:30GLOBENEXGEL to Present at the iAccess Alpha Best Ideas Spring..
22/02/202406:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/02/202406:15EDGAR2Form 8-K - Current report
22/02/202406:05GLOBENEXGEL Announces $975,000 Registered Direct Offering Led by..
31/01/202423:05EDGAR2Form 8-K - Current report
18/01/202423:00GLOBENEXGEL to Present at The Microcap Conference, January 30th..
17/01/202406:30EDGAR2Form 8-K - Current report
09/01/202422:30GLOBENEXGEL Subsidiary, CG Converting and Packaging, Begins..
30/12/202306:30EDGAR2Form 8-K - Current report
27/12/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202306:52EDGAR2Form 8-K - Current report
11/12/202322:15EDGAR2Form 8-K - Current report
11/12/202322:00GLOBENEXGEL Announces Partnership with STADA to Distribute and..
05/12/202322:10EDGAR2Form 8-K - Current report
05/12/202322:00GLOBENEXGEL Acquires Kenkoderm Psoriasis Skincare Line
14/11/202307:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202307:10EDGAR2Form 8-K - Current report
14/11/202306:05GLOBENEXGEL Reports Record Third Quarter 2023 Revenue of $1.2..
02/11/202322:00GLOBENEXGEL to Report Third Quarter 2023 Financial Results on..
30/10/202321:30EDGAR2Form 8-K - Current report
30/10/202321:00GLOBENEXGEL Secures Supply Agreement with AbbVie
26/09/202322:49GLOBENEXGEL to Participate in the LD Micro Main Event XVI on..
15/09/202307:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/08/202307:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/08/202305:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/08/202305:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/08/202305:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202306:29EDGAR2Form 8-K - Current report
15/08/202305:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/08/202305:05GLOBENEXGEL Reports Second Quarter 2023 Record Revenue of $1.17..
02/08/202322:00GLOBENEXGEL to Report Second Quarter 2023 Financial Results on..
19/07/202322:10GLOBENEXGEL Partners with Enigma Health to Distribute its Leading..
15/06/202322:00GLOBENEXGEL to Participate in Maxim Group’s Virtual Healthcare..
24/05/202322:00GLOBENEXGEL to Participate in the LD Micro Invitational XIII on..
16/05/202305:05GLOBENEXGEL Reports First Quarter 2023 Financial Results
09/05/202322:15GLOBENEXGEL to Report First Quarter 2023 Financial Results on May..

최근 히스토리

Delayed Upgrade Clock